William R. Larue, Director at Tracon Pharmaceuticals, Inc. (TCON), sold 120 shares at $1.26 ($151) on 2022-12-21, disclosed to the SEC on 2023-01-19.
Open-market sale of $151 TCON by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CADX | SELL | 2013-12-18 | $78K | — | Filing → |
| CADX | SELL | 2013-11-18 | $263K | — | Filing → |
| CADX | SELL | 2013-07-17 | $65K | — | Filing → |